3of the prostate and seminal vesicles[A].In Walsh PC,Retik A B.Vaughan E D,et al.Campbell's Urology[M].7thed,New York:Philadephia,Saunder,1998.1379-1428.
4Connell JM.5 Alpha2reductase in prostate disease[A].Kir-by R,Connell J M,Fitzpatrick J,et al.Textbook of prostatic hyperplasia[M].London:ISIS Medical Media,1996.85-90.
5Gleave ME,Goldenberg SL,Chin JL,et al.Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy:biochemical and pathological effects[J].J Urol,2001,166:500-506.
6Messing EM,Manola J,SarosdyM,et al.Immediate hormonal therapy compared with observation after radical prostatectomy in men with nodep sitive prostate cancer[J].N Ensl J Med,1999,341:1781-1788.
7Schulman CC,Debruyne FM,ForsterG,et al.42Year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical p rostatectomy in T2-3N0M0 prostate cancer.European Study Group on Neoadjuvant Treatment of Prostate Cancer[J].Eur Urol,2000,38:706-713.
二级参考文献14
1Partin AW, Coffey DS. The molecular biology, endocrinology, and physiology of the prostate and seminal vesicles[ A]. In Walsh PC,Retik A B, Vaughan E D, et al. Campbell's Urology. 7^th ed.New York: Philadephia, Saunder, 1998. 1379-1428.
2Connell JM. 5 Alpha-reductase in prostate, disease [ A ]. In : Kirby R, Connell J M, Fitzpatrick J, et al. Textbook of prostatic hyperplasia. London : ISIS Medical Media. 1996. 85-90.
3Sneller ZW, Hop WC, Carpentier PJ, et al: Prognosis and prostatic volume changes during endocrine management of prostate cancer: A longitudinal study[J]. J Urol, 1992, 147(3 Pt 2) :962 -966.
5Chawnshang Chang.A dominant negative mutant of androgen receptor coactivator ARA54, suppresses androgen receptor transactivation in prostate cancer cell[].J Urol th AUA meeting #.
6Prehen RT.On the prevention and therapy of prostate cancer by androgen administration[].Cancer Research.1999
7Umekita Y,Kolontis JM,Shutsung L.Human prostate tumor growth in athymic mice-inhibition by androgen and stimulation by finasteride[].Proceedings of the National Academy of Sciences of the United States of America.1996
8Hai Yen E,Shiming Chang,Chung WK,et al.Androgen-repressed phenotype in human prostate cancer[].Proceedings of the National Academy of Sciences of the United States of America.1996
9Din Lii Lin,Zhi Yao,Keller ET.Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression[].Clinical Cancer Research.2001
10Okamoto M,Lee C,Oyasu R.Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro[].Cancer Research.1996
